PYC Therapeutics Ltd (PYC) — Cash Flow Reinvestment Rate

Latest as of June 2017: 0.00x

PYC Therapeutics Ltd (PYC) has a Cash Flow Reinvestment Rate of 0.00x as of June 2017, reinvesting AU$608.00 (capex AU$608.00 ) from operating cash flow of AU$1.73 Million. See free cash flow generation of PYC Therapeutics Ltd to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

AU$608.00

Capex + Investments

Operating Cash Flow

AU$1.73 Million

AUD

Capital Expenditures

AU$608.00

AUD

PYC Therapeutics Ltd Cash Flow Reinvestment Rate (2004–2004)

Historical reinvestment intensity for PYC Therapeutics Ltd across 1 annual periods. For the full cash flow conversion analysis, see PYC cash flow conversion.

Annual Cash Flow Reinvestment Rate for PYC Therapeutics Ltd (2004–2004)

Year-by-year capital reinvestment analysis for PYC Therapeutics Ltd. See financial flexibility index of PYC Therapeutics Ltd to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (AUD)	Operating CF	Capex	YoY Change
2004	0.11x	AU$3.00K	AU$28.00K	AU$3.00K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow